[XENE] YoY Quarter Result on 31-Dec-2016 [#Q4]

Stock
[XENE] Xenon Pharmaceuticals Inc.
Announcement Date
08-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- 22.17%
YoY- -52.50%
Quarter Report
XENE's Result
XENE's Financial Summary
View:
Show?
Quarter Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 3,329 6,000 16 376 3,227 4,878 5,583 -8.25%
PBT -11,412 -8,558 -8,065 -6,004 -3,937 1,224 2,514 -
Tax -36 357 14 542 1,334 0 8 -
NP -11,376 -8,558 -8,065 -6,004 -3,937 1,224 2,514 -
Tax Rate - - - - - 0.00% -0.32% -
Total Cost 14,705 14,558 8,081 6,380 7,164 3,654 3,069 29.82%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin -341.72 -142.63 -50,406.25 -1,596.81 -122.00 25.09 45.03 -
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -0.34 -0.34 -0.45 -0.33 -0.27 0.09 0.28 -
EPS Diluted -0.34 -0.33 -0.45 -0.33 -0.27 0.09 0.26 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.